Get started
Author

Carlo Barone

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
2017 · Maurizio Muscaritoli, the PreMiO Study Group, et al. · Oncotarget · 441
PDF
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
2019 · Charles S Fuchs, Kohei Shitara, et al. · The Lancet Oncology · 290
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
2021 · Ina Valeria Zurlo, Mattia Schino, et al. · Cancer Immunology Immunotherapy · 80
PDF
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
2017 · Jean-François Emile, Catherine Julié, et al. · European Journal of Cancer · 48
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
2017 · Heikki Joensuu, Jean-Yves Blay, et al. · British Journal of Cancer · 43
Does Sarcopenia Affect Outcome in Patients with Non-Small-Cell Lung Cancer Harboring EGFR Mutations?
2018 · Sabrina Rossi, Vincenzo Di Noia, et al. · Future Oncology · 40
Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial
2009 · Desmond Curran, Carmelo Pozzo, et al. · Quality of Life Research · 40
PDF
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
2010 · Barbara Rossi, Giovanni Schinzari, et al. · BMC Musculoskeletal Disorders · 35
PDF
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen
1998 · Carlo Barone, Domenico C. Corsi, et al. · Cancer · 33
Time profile of adverse events (AEs) from regorafenib (REG) treatment for metastatic colorectal cancer (mCRC) in the phase III CORRECT study.
2013 · Axel Grothey, Alberto F. Sobrero, et al. · Journal of Clinical Oncology · 32
Anastrozole-related acute hepatitis with autoimmune features: a case report
2011 · Alessandro Inno, Michele Basso, et al. · BMC Gastroenterology · 32
PDF
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
2016 · Riccardo Ricotta, Antonella Verrioli, et al. · ESMO Open · 31
PDF
Time course of regorafenib-associated adverse events in the phase III CORRECT study.
2013 · Axel Grothey, Eric Van Cutsem, et al. · Journal of Clinical Oncology · 28
A survey of therapy for advanced renal cell carcinoma
2009 · Michele Basso, Alessandra Cassano, et al. · Urologic Oncology Seminars and Original Investigations · 28
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis
2015 · Sabrina Rossi, Ettore D’Argento, et al. · Molecular Diagnosis & Therapy · 24
Nevirapine restores androgen signaling in hormone‐refractory human prostate carcinoma cells both in vitro and in vivo
2009 · Matteo Landriscina, Cinzia Bagalà, et al. · The Prostate · 24
Regorafenib (REG) in progressive metastatic colorectal cancer (mCRC): Analysis of age subgroups in the phase III CORRECT trial.
2013 · Eric van Cutsem, Alberto Sobrero, et al. · Journal of Clinical Oncology · 23
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
2017 · Salvatore Corallo, Ettore D’Argento, et al. · Targeted Oncology · 22
Analysis of plasma protein biomarkers from the CORRECT phase III study of regorafenib for metastatic colorectal cancer.
2013 · Heinz-Josef Lenz, Eric Van Cutsem, et al. · Journal of Clinical Oncology · 12
Population Pharmacokinetics Analysis of Regorafenib and Its Active Metabolites From the Phase III Correct Study of Metastatic Colorectal Cancer
2013 · Zuzana Jirakova Trnkova, Axel Grothey, et al. · Annals of Oncology · 7
Ketoalkalosis as a result of triple derangement of acid-base equilibrium in a diabetic patient
1985 · Aldo V. Greco, Aldo Bertoli, et al. · Acta Diabetologica · 7
Paradox CA 15–3 Increase in Metastatic Breast Cancer Patients Treated with Everolimus: a Change of Paradigm in a Case Series
2016 · Armando Orlandi, Carmela Di Dio, et al. · Biomarkers in Medicine · 4
c-Myc expression as a key-marker in the colorectal cancer resistance to EGFR inhibitors.
2016 · Maurizio Martini, Michele Basso, et al. · Journal of Clinical Oncology · 3
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review
2017 · Sabrina Rossi, Teresa Congedo, et al. · Journal of Gastrointestinal Oncology · 2
PDF
Pharmacokinetics of Sunitinib in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
2014 · Biolato Marco, Basso Michele, et al. · Annals of Oncology · 2
Works count: 29
Citation count: 1,334
H-index: 18
I10-index: 19
Year
Topic
Type